Skip to main content
Premium Trial:

Request an Annual Quote

Accelr8 Shares More Than Double in February to Lead GWDN Index

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Shares Accelr8 more than doubled in the month of February, as the firm disclosed mid-month that its technology evaluation agreement with Novartis Vaccines and Diagnostics has been extended to June 30, 2011.

As part of that pact, the firm said as of Jan. 31, it has received an aggregate amount of roughly $640,000 from Novartis, and it anticipates receiving "not less than $140,000 more pursuant to these agreements."

Accelr8 was by the far the biggest gainer among stocks last month in the GenomeWeb Daily News Index. Several firms had low double-digit increases, as many companies in the Index reported their fourth-quarter and full-year 2010 financial results.

Among those firms were Beckman Coulter (+15 percent), which is in the process of being acquired by Danaher for $6.8 billion, Genomic Health (+13 percent), Qiagen (+12 percent), Cepheid (+12 percent), Luminex (+11 percent), and Bruker (+10 percent).

The decliners for the month were led by Rosetta Genomics and Vermillion, which both fell more than 30 percent.

Rosetta's shares fell after the company said that it would issue more than 7.9 million shares of common stock in concurrent private placement and registered direct offerings aimed at raising $6 million.

Vermillion also raised money during February, selling 4 million shares of common stock at $5.45 per share, bringing in net proceeds of around $20.2 million.

Overall, the GWDN Index rose 3 percent in February, matching the gains for the Dow Jones Industrial Average and the Nasdaq. The Nasdaq Biotech index was up 1 percent for the month.


The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.